Category: Uncategorized
Study suggests AI can predict risk of lung cancer returning using CT scans
Findings from the OCTAPUS-AI study of over 900 patients used machine learning to see how accurately it could predict recurrence. From the Royal Marsden NHS Foundation Trust website – published 22 December 2022 Artificial intelligence (AI) could help identify the risk of cancer returning in non-small cell lung cancer (NSCLC) patients using CT scans, according […]
New report highlights ‘crucial’ role of lung cancer nurse specialists
The UK Lung Cancer Coalition has published a 32-page report which highlights the “crucial” role of lung cancer clinical nurse specialists (LCNSs) in tackling health inequalities in this area of care. It also makes clear that the Covid-19 pandemic, together with the current cost of living crisis, have shone a light on the huge […]
Member activity during Lung Cancer Awareness Month – UPDATED
Lung Cancer Awareness Month (#LCAM) 2022 – a round-up of members’ activities and campaigns LCAM, which is observed annually in November, highlights the need for more research to be conducted while cultivating a better understanding of the disease. Lung cancer is the leading cause of cancer deaths in men and women worldwide. The disease remains […]
FairLife holds annual conference: Lung Cancer in the Age of Innovation
FairLife LCC, the first non-profit social organization in Greece exclusively dedicated to lung cancer, is hosting its annual conference, Lung Cancer in the Age of Innovation. The importance of early screening, new therapeutic approaches – A modern approach to molecular testing and clinical studies Date: Wednesday, November 23, 2022 at 10:00 – 18:30 EET […]
The time to act is now for EU-wide lung cancer screening – Lung Cancer Policy Network article
November is Lung Cancer Awareness Month – a time to reflect on why progress in survival on lung cancer lags so significantly behind other cancers, and what can be done to change it. The Lung Cancer Policy Network, an international group of clinicians, patients, researchers and industry representatives jointly committed to improving survival from lung […]
Updates on member activity during Lung Cancer Awareness Month
Lung Cancer Awareness Month (#LCAM) 2022 – a round-up of members’ activities and campaigns LCAM, which is observed annually in November, highlights the need for more research to be conducted while cultivating a better understanding of the disease. Lung cancer is the leading cause of cancer deaths in men and women worldwide. The disease remains […]
ILC2 Round 4 application deadline extended
Deadline extended! Don’t waste this opportunity to apply for funding. ILC2 from Lung Ambition Alliance is a platform to help fund local projects across the world. The aim is to support patient and caregiver non-profit organisations to improve the quality of care and the patient experience in #lungcancer. Please note: the ILC2 Round 4 application portal […]
How Air Pollution May Cause Lung Cancer – research data shared at ESMO
From ILCN News, 11 October 2022 DURING ESMO CONGRESS 2022, PROF. CHARLES SWANTON SHARED DATA THAT SHOW CELLS WITH EGFR AND KRAS GENE MUTATIONS CAN TURN CANCEROUS WHEN EXPOSED TO POLLUTION FROM THE BURNING OF FOSSIL FUELS. By: Erin Jungmeyer In: MEETING NEWS, RISK ASSESSMENT AND REDUCTION Charles Swanton, PhD, FRCP Editor’s Note: For more research on the […]
Major step towards lung cancer screening for Australia
Chair of the GLCC, Prof Matthew Peters, has welcomed a ”major step forward” towards a national lung cancer screening programme in Australia. The Australian Government has received advice regarding a national lung cancer screening program from the independent Medical Services Advisory Committee. Cancer Australia, the Government’s lead agency for cancer control, initiated an application to […]
Lung Ambition Alliance ILC2 Round 4 now open
The Challenge There remains considerable variation in the management of lung cancer around the world. Access for patients to important diagnostics, treatments and support programs varies markedly. Our Solution ILC2: Initiatives in Lung Cancer Care, a Global Funding Opportunity to Transform Patient Care and Improve the Patient Experience The ILC2 program supports patient and caregiver organizations registered […]
UK National Screening Committee recommends targeted screening for lung cancer
The UK National Screening Committee (UK NSC) has today (Thursday 29 September) given a positive recommendation for the introduction of the country’s first targeted national cancer screening programme. At its first meeting following the approval of its expanded remit, the committee recommended that the 4 UK nations should move towards implementing a targeted national lung […]
COVID-19 A Roadblock to Effective Cancer Care in 2022
From the IASLC Lung Cancer News A JOINT SESSION AT WCLC EXPLORED THE IMPACT THE PANDEMIC HAS HAD ON THE PREVENTION, DIAGNOSIS, AND MANAGEMENT OF THORACIC MALIGNANCIES. By Leah Lawrence, on August 30 2022 – read it online here. As she introduced a WCLC 2022 educational session presented by IASLC and the Global Lung Cancer […]
